SBI Securities Co. Ltd. Buys Shares of 22,743 Nu Skin Enterprises, Inc. (NYSE:NUS)

SBI Securities Co. Ltd. bought a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 22,743 shares of the company’s stock, valued at approximately $157,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Ballentine Partners LLC boosted its stake in shares of Nu Skin Enterprises by 15.5% during the 4th quarter. Ballentine Partners LLC now owns 20,856 shares of the company’s stock worth $144,000 after purchasing an additional 2,800 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Nu Skin Enterprises by 3.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 116,424 shares of the company’s stock worth $858,000 after buying an additional 4,125 shares in the last quarter. Inspire Investing LLC grew its holdings in shares of Nu Skin Enterprises by 7.8% during the fourth quarter. Inspire Investing LLC now owns 65,418 shares of the company’s stock worth $451,000 after buying an additional 4,728 shares in the last quarter. Covestor Ltd grew its holdings in shares of Nu Skin Enterprises by 110.9% during the third quarter. Covestor Ltd now owns 10,140 shares of the company’s stock worth $75,000 after buying an additional 5,333 shares in the last quarter. Finally, US Bancorp DE grew its holdings in shares of Nu Skin Enterprises by 424.2% during the fourth quarter. US Bancorp DE now owns 7,460 shares of the company’s stock worth $51,000 after buying an additional 6,037 shares in the last quarter. 82.84% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

NUS has been the subject of a number of recent research reports. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. DA Davidson lowered their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, December 20th.

Nu Skin Enterprises Price Performance

Nu Skin Enterprises stock opened at $8.04 on Friday. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $14.04. The firm has a 50 day moving average price of $7.07 and a 200 day moving average price of $7.23. The company has a market cap of $399.62 million, a price-to-earnings ratio of -2.72 and a beta of 1.17. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $445.55 million during the quarter, compared to the consensus estimate of $441.10 million. Sell-side analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were issued a $0.06 dividend. The ex-dividend date was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a yield of 2.99%. Nu Skin Enterprises’s payout ratio is -8.14%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.